Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 7 is a member of the C2H2-type zinc finger protein family and is predicted to act as a DNA-binding transcription factor regulating transcription by RNA polymerase II[1][5]. It contains structured zinc finger domains that allow sequence-specific binding to DNA, participating in the modulation of gene expression. ZNF7 is localized predominantly in the nucleus and may be involved in fine regulatory control of cell processes, although its precise endogenous target genes and regulatory roles remain to be fully characterized[1][5]. Mutations in related domains, such as the ZnF7 domain of the A20 protein, have been tied to immune dysregulation and autoinflammatory responses in animal models, suggesting that ZNF7 or its family members may have roles in inflammatory and immune processes[1][5]. General functions of C2H2-type zinc finger proteins include transcription regulation, chromatin remodeling, genome stability, and mediation of cell differentiation and development[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 7 (ZNF7).